How can you tell if your myopia management strategy has been a success? Our new Myopia Profile ‘Managing Myopia Guidelines’ infographics translate research into practice, providing advice on gauging success by both refraction and axial length outcomes. Given that refraction is universally measured in clinical myopia practice, there is particular emphasis on understanding how much refraction change after a year of treatment indicates whether expected efficacy for that intervention has been attained.
Podcast summary: Dr Monica Jong, Executive Director of the International Myopia Institute, founded by the Brien Holden Vision Institute, tells
We’re excited to release our new clear, concise and clinically relevant infographic Which option to slow myopia?to help you with what we have learnt is the main practitioner need in myopia management, and the most popular discussion topic in the Myopia Profile Facebook group – guidance in selecting the right treatment for your patient. A world first, evidence based decision making tool.
Most eye care practitioners don’t routinely measure axial length in clinical practice, mainly due to lack of access to the instrumentation and its expense. This is not the only reason, though, that axial length (AXL) measurement is a bit of a problematic measure for gauging myopia management success in a clinical setting.
Let’s cut to the chase – until further notice, you can consider low dose (0.05%) atropine, soft multifocal CL’s and OrthoK as all quite similar in terms of their myopia control efficacy, being around 50% on average. A network meta-analysis of sixteen different interventions studied for myopia control showed these options to all have similar efficacy when their refractive and axial length outcomes were put on a level playing field.